LeMaitre Vascular, Inc.
LMATNASDAQHealthcare● Active
$95.11
+$0.63(+0.67%)
Market Cap$2.2B
P/E Ratio—
52W High$118.01
52W Low$79.01
LeMaitre Vascular, Inc. (LMAT) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LMAT · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.06B | $0.04B | $0.03B | $0.02B | $0.03B |
| Depreciation & Amort. | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Change in Working Capital | ($0.00B) | ($0.02B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Net Cash from Operations | $0.08B | $0.04B | $0.04B | $0.03B | $0.04B |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.64B) | ($0.28B) | ($0.02B) | ($0.01B) | ($0.06B) |
| Sales of Investments | $0.59B | $0.08B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.06B) | ($0.20B) | ($0.02B) | ($0.01B) | ($0.06B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.02B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Debt Issued / Repaid | $0.00B | $0.17B | $0.00B | $0.00B | ($0.04B) |
| Net Cash from Financing | ($0.01B) | $0.16B | ($0.01B) | ($0.01B) | $0.01B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.07B | $0.04B | $0.03B | $0.02B | $0.03B |
| FCF Margin %(computed) | 29.83% | 16.90% | 15.24% | 13.70% | 19.57% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more LeMaitre Vascular, Inc. data
About LeMaitre Vascular, Inc. (LMAT) Cash Flow Statement
LeMaitre Vascular, Inc. generated operating cash flow of $0.08B and free cash flow of $0.07B for 2025 — a FCF margin of 29.83%. Capital expenditure was ($0.01B).
Frequently asked questions
LMAT · 4 questionsLeMaitre Vascular, Inc. generated free cash flow of $0.07B for 2025, up 100.4% year-over-year.
LMAT free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10